Clinical trial
Evaluation of Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias 3 Months After Treatment: a Multicenter, Single-blind, Randomized Controlled Trial
NCT07059819 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias 3 Months After Treatment: a Multicenter, Single-blind, Randomized Controlled Trial
- Lead sponsor
- First Hospital of China Medical University
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- November 2, 2024
- Completion date
- October 1, 2026
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical intraepithelial neoplasia (cin), human papillovirus